Cheng Du Sheng Nuo Biotec Co., Ltd. (688117.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 23.70

From 52W high−27.28%

Volume6.08M

Market capCNY 5.33B

P/E (TTM)33.8x

P/S (TTM)6.6x

Div yield2.00%

Key dataSep 18, 2026

Open

CNY 23.70

From 52W high

−27.28%

Volume

6.08M

Market cap

CNY 5.33B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

33.8x

RSI (14)

49.8

MomentumView details →

1D Return

−6.17%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

33.8x

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

6.6x

P/B (TTM)

4.7x

ProfitabilityView details →

Gross Margin

58.69%

Net Margin

22.11%

EBITDA Margin

32.44%

ROE (TTM)

15.75%

ROA (TTM)

8.82%

Asset Turnover

0.41x

GrowthView details →

Revenue YoY

+49.42%

EPS YoY

+82.60%

FCF YoY

+107.53%

Revenue CAGR 3Y

+23.28%

EPS CAGR 3Y

+19.91%

EBITDA YoY

—

MomentumView details →

1D Return

−6.17%

YTD Return

—

1Y Return

—

RSI (14)

49.8

vs 50D SMA

−2.69%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.44x

Current Ratio

2.12x

Quick Ratio

1.31x

Div Yield

2.00%

Div Rate

CNY 0.48

Div Growth 1Y

−7.77%

EarningsView details →

EPS (Actual)

CNY 0.31

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

176.82%

Financials snapshotView financials →

Revenue (TTM)

801.40M

Net Income (TTM)

177.17M

Op. CF (TTM)

147.56M

Latest newsMore news →

Shengnuo Biopharmaceutical's wholly-owned subsidiary Chengdu Shengnuo Biopharmaceutical received a drug registration certificate from China's National Medical Products Administration for linaclotide capsules (290μg), approving the product for market.17d ago

Sino Bio's wholly-owned subsidiary Chengdu Sino Bio Pharmaceutical received approval from China's National Medical Products Administration for the registration of its active pharmaceutical ingredient terlipressin acetate, packaged at 10g per bottle.23d ago

Similar companies

人民同泰600829.SH Shenzhen Hepalink Pharmaceutical Group Co., Ltd.09989.HK 吉贝尔688566.SH 津药药业600488.SH 珍宝岛603567.SH 华纳药厂688799.SH Find similar companies →

Latest newsMore news →

Shengnuo Biopharmaceutical's wholly-owned subsidiary Chengdu Shengnuo Biopharmaceutical received a drug registration certificate from China's National Medical Products Administration for linaclotide capsules (290μg), approving the product for market.17d ago Sino Bio's wholly-owned subsidiary Chengdu Sino Bio Pharmaceutical received approval from China's National Medical Products Administration for the registration of its active pharmaceutical ingredient terlipressin acetate, packaged at 10g per bottle.23d ago